Start for free
Start for free
Lonza logo

Lonza

Europe, Basel-Stadt, Switzerland, Basel

Description

Lonza Group supplies products and services to pharmaceutical and agrochemical industries.

Investor Profile

Lonza has made 7 investments, with 0 in the past 12 months and 29% as lead.

Stage Focus

  • Series A (43%)
  • Series Unknown (14%)
  • Series B (14%)
  • Corporate Round (14%)
  • Undisclosed (14%)

Country Focus

  • United States (71%)
  • Germany (14%)
  • Italy (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Biopharma
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Consumer Electronics
  • Service Industry
  • Water Purification
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lonza frequently co-invest with?

MI
Myeloma Investment Fund
North America, Massachusetts, United States, Brookline
Co-Investments: 1
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
Atlas Venture
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Vertex Ventures
Vertex Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Burrill & Company
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 1
F-Prime Capital
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Leaps by Bayer
Leaps by Bayer
Europe, Nordrhein-Westfalen, Germany, Leverkusen
Co-Investments: 1
Partners Innovation Fund
Partners Innovation Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by Lonza?

Indapta Therapeutics

San Francisco, California, United States

Indapta Therapeutics is a privately held biotechnology company.

BiopharmaBiotechnologyMedical
Series AFeb 10, 2022
Amount Raised: $50,000,000
Affinia Therapeutics

Waltham, Massachusetts, United States

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BMay 3, 2021
Amount Raised: $110,000,000
Affinia Therapeutics

Waltham, Massachusetts, United States

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series AMar 31, 2020
Amount Raised: $60,000,000
Exosomics Siena

Siena, Toscana, Italy

Exosomics offers a portfolio of services supporting.

Health CareMedicalMedical Device
UndisclosedMay 16, 2017
ConnectedYard (pHin)

San Jose, California, United States

pHin - The complete Smart Water Care Solution for pool and hot tub care

Consumer ElectronicsService IndustryWater Purification
Series ADec 2, 2016
Amount Raised: $7,000,000
Odyssey Thera

San Ramon, California, United States

Odyssey Thera develops cellular pharmacology strategy for the identification of medicines for cancer and other human diseases.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series UnknownFeb 14, 2013
Amount Raised: $2,800,000
Cilian AG

Münster, Nordrhein-Westfalen, Germany

Cilian AG is a biotechnology company developing and marketing a novel protein expression system based on ciliates.

BiotechnologyGeneticsLife Science
Corporate RoundOct 22, 2009
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator